Epirubicin, Oxaliplatin, and Capecitabine or Docetaxel and Oxaliplatin in Treating Patients With Advanced Esophageal Cancer, Gastroesophageal Junction Cancer, or Stomach Cancer

Last updated: June 30, 2010
Sponsor: All Ireland Cooperative Oncology Research Group
Overall Status: Active - Recruiting

Phase

2

Condition

Esophageal Cancer

Gastrointestinal Diseases And Disorders

Esophageal Disorders

Treatment

N/A

Clinical Study ID

NCT00806949
CDR0000629056
EU-20890
ICORG-06-05
EUDRACT-2006-003332-29
  • Ages > 18
  • Both

Study Design

Total Participants: 140
Study Start date:
May 01, 2007
Estimated Completion Date:

Connect with a study center

  • Cork University Hospital

    Cork,
    Ireland

    Active - Recruiting

  • Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital

    Dublin, 24
    Ireland

    Active - Recruiting

  • Beaumont Hospital

    Dublin, 9
    Ireland

    Active - Recruiting

  • Mater Private Hospital

    Dublin, 7
    Ireland

    Active - Recruiting

  • St. James's Hospital

    Dublin, 8
    Ireland

    Active - Recruiting

  • Galway University Hospital

    Galway,
    Ireland

    Active - Recruiting

  • Waterford Regional Hospital

    Waterford,
    Ireland

    Active - Recruiting

  • Belfast City Hospital Trust Incorporating Belvoir Park Hospital

    Belfast, Northern Ireland BT9 7AB
    United Kingdom

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.